SKI Market

A+| A| A-|

Indian Indices

Sensex

76,200.68 -893.39
( -1.16%)

Global Indices

Nasdaq

51,748.06 162.36
(0.31%)

Dow Jones

7,496.17 -25.41
(-0.34%)

Hang Seng

70,132.76 -2,221.20
(-3.07%)

Nikkei 225

10,441.93 78.66
(0.76%)

Forex

USD-INR

94.32 -0.07
(-0.07%)

EUR-INR

108.15 -0.25
(-0.23%)

GBP-INR

124.70 -0.38
(-0.31%)

JPY-INR

0.58 0.00
(-0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

132.2958859

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

44.14

40073.84

EPS(TTM)

Face Value()

Div & Yield %

53.59

2.41

Back

dhatre udyog ltd

EID Parry (India) consolidated net profit rises 19.13% in the December 2025 quarter

Feb 13,2026

Net profit of EID Parry (India) rose 19.13% to Rs 232.15 crore in the quarter ended December 2025 as against Rs 194.87 crore during the previous quarter ended December 2024. Sales rose 18.29% to Rs 10315.58 crore in the quarter ended December 2025 as against Rs 8720.35 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	10315.58	8720.35	18
OPM %	8.10	7.95	-
PBDT	791.46	712.20	11
PBT	587.93	581.71	1
NP	232.15	194.87	19

76,200.68 -893.39 ( -1.16%)

51,748.06 162.36 (0.31%)

7,496.17 -25.41 (-0.34%)

70,132.76 -2,221.20 (-3.07%)

10,441.93 78.66 (0.76%)

94.32 -0.07 (-0.07%)

108.15 -0.25 (-0.23%)

124.70 -0.38 (-0.31%)

0.58 0.00 (-0.32%)